Evidence map›Paper›PMID 39006922›Full record

ArticleComputational and structural biotechnology journal2024

Transcriptomic investigations of polymyxins and colistin/sulbactam combination against carbapenem-resistant

Xingchen Bian, Mengyao Li, Xiaofen Liu, Yan Zhu, Jian Li, Phillip J Bergen, Wanzhen Li, Xin Li, Meiqing Feng, Jing Zhang

Abstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Disruption ofVirulence · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Species-Specific Stress Responses to Selenium Nanoparticles inNanomaterials (Basel, Switzerland) · 2025
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xingchen BianInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Mengyao LiDepartment of Critical Care Medicine, The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), Shenzhen, China.
Xiaofen LiuInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Yan ZhuTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, China.
Jian LiBiomedicine Discovery Institute and Department of Microbiology, Monash University, Melbourne, Australia.
Phillip J BergenBiomedicine Discovery Institute and Department of Microbiology, Monash University, Melbourne, Australia.
Wanzhen LiInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Xin LiInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Meiqing FengDepartment of biological medicines & Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai, China.
Jing ZhangInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbapenem-resistant

Indexed as

Carbapenem-resistant Acinetobacter baumanniiCombinationPolymyxinsSulbactamTranscriptomics

Identifiers

PMID39006922
PMCPMC11245955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.